Paul B. Freeman OD, FAAO, FOVDR
Chief, Low Vision Rehabilitation Services, Allegheny General Hospital, Pittsburgh, Pennsylvania; Clinical Professor, University of the Incarnate Word, Rosenberg School of Optometry, San Antonio, TexasDr. Paul B. Freeman is the Chief of Low Vision Rehabilitation Services at Allegheny General Hospital in Pittsburgh, Pennsylvania, and he provides low vision rehabilitation services at Keystone Blind Association in Hermitage, Pennsylvania, and at Beaver County Association for the Blind in Conway, Pennsylvania. Dr. Freeman is also a Clinical Professor at the University of the Incarnate Word, Rosenberg School of Optometry in San Antonio, Texas.
Dr. Freeman’s clinical interests include visual impairment, traumatic brain injury, visual aspects of driving, and learning-related vision problems. He has been an investigator in a number of vision research projects to determine the efficacy of sophisticated low vision devices, to assess the psychological implications of low vision, and to explore the relationship of vision and the learning process.
A Fellow of the American Academy of Optometry and a Diplomate in Low Vision, Dr. Freeman is also a Fellow of Optometric Vision Development and Rehabilitation Association. He lectures both nationally and internationally and has authored numerous articles and book chapters. Currently, he is Editor-in-Chief of Optometric Clinical Practice.
Recent Contributions to PracticeUpdate:
- Association of Vision Impairment With Preventive Care Use in Older Adults
- Depressive Symptoms in Patients With Neovascular Age-Related Macular Degeneration
- Safety and Efficacy of a 3-D Visualization Helmet for Vitreoretinal Surgery
- Management of Retinal Vein Occlusion
- Factors Associated With Impaired Motor Skills in Strabismic and Anisometropic Children
- Reading With Central Vision Loss
- Visual Acuity Inadequately Reflects Vision-Related QoL After Macula-Off Retinal Detachment Surgery
- Treatment Approaches to Macular Degeneration During the COVID-19 Epidemic
- Immunomodulatory Therapy in Noninfectious Uveitis During the COVID-19 Pandemic
- Intravitreal Dexamethasone Implant 1 Month Before vs Concomitant With Cataract Surgery in DME